The day's move was broad, with all 10 S&P 500 industry sectors higher on the day. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.
The S&P is on track for its 52nd record close of the year, the most since 1995 and the fourth-best annual record ever, while the Dow is on track for its seventh straight daily raise, its longest streak since March 2013.
"The overall trend remains higher, but we're reaching a point where we're overbought. Six percent since last Tuesday is such a strong move in such a short period of time, even if bulls have the upper hand in the longer term," said Adam Sarhan, chief executive of Sarhan Capital in New York.
Recent gains have come on strong economic data, including a bullish read on economic growth earlier this week, as well as accommodative measures from central banks. Chinese media this week reported that the country's central bank was moving to further ease liquidity conditions inside banks.
The Nasdaq biotech index .NBI rose 1.7 percent, though it remains down 3.8 percent in a week marked by heavy volatility. Celgene Corp (CELG.O) rose 2.9 percent to $112.73 as the S&P 500's biggest percentage gainer, followed by Gilead Sciences (GILD.O), up 2.6 percent to $93.66.
At 9:55 a.m. (1455 GMT) the Dow Jones industrial average .DJI rose 63 points, or 0.35 percent, to 18,093.21, the S&P 500 .SPX gained 9.07 points, or 0.44 percent, to 2,090.95 and the Nasdaq Composite .IXIC added 23.27 points, or 0.49 percent, to 4,796.75.
For the week, the Dow is up 1.6 percent, the S&P 500 is up 1 percent and the Nasdaq is up 0.6 percent. It is the second straight weekly gain for all three, and the ninth positive week in the past ten for the Dow and S&P.
The S&P Retail index .SPXRT rose 0.6 percent in the first trading session after Christmas. Among notable names, Best Buy Co (BBY.N) rose 1.1 percent to $39.31 while Macy's Inc (M.N) dipped 0.2 percent to $64.14.
"The data still isn't in yet, but things are looking positive since the shopping season coincided with a big drop in crude oil, which means lower gas prices," Sarhan said. "That translates to more disposable income, which could mean stronger retail sales."
Advancing issues outnumbered declining ones on the NYSE by 2,112 to 617, for a 3.42-to-1 ratio on the upside; on the Nasdaq, 1,654 issues rose and 640 fell for a 2.58-to-1 ratio favoring advancers.
The benchmark S&P 500 index posted 45 new 52-week highs and 5 new lows; the Nasdaq Composite recorded 47 new highs and 7 new lows.
